New Releases from DOJO E-cigarette: iMate X 20K, PIXEL, BLAST2000

Feb.12.2025
New Releases from DOJO E-cigarette: iMate X 20K, PIXEL, BLAST2000
DOJO introduces new e-cigarette products iMate X 20K, PIXEL, and BLAST2000 GO on brand website and TPE exhibition.

Special announcement:

This article is for internal industry communication only and does not make any recommendations for brands or products.

The images presented in this article are solely used to depict facts and are not intended as advertisements for any products.

This article is prohibited for minors to access.


 

Recently, 2Firsts noticed that the e-cigarette brand DOJO has recently launched new e-cigarette products iMate X 20K, PIXEL, and BLAST2000 GO on its official website. These new products have also been released at the TPE Expo in Las Vegas, USA.

 

Specifically, the main product parameters of the DOJO iMate X 20K are shown in the table below.

New Releases from DOJO E-cigarette: iMate X 20K, PIXEL, BLAST2000
DOJO PIXEL parameters | Mapping: 2FIRSTS

 

According to Vaping360, the DOJO iMate X 20K is the flagship product in the iMate series.

New Releases from DOJO E-cigarette: iMate X 20K, PIXEL, BLAST2000
The world's first e-cigarette equipped with a gravity sensor and dual-pixel screen" | Image source: vaping360

The main feature of this product lies in its magnetic suction technology and sliding rail mechanism: the pod section is equipped with a separate 400mAh battery, allowing users to easily replace the pod through magnetic suction connection and sliding rail mechanism. The magnetic battery and screen module can be attached to the pod and other metal surfaces.

 

Another product is DOJO PIXEL, whose main product specifications are shown in the table below:

New Releases from DOJO E-cigarette: iMate X 20K, PIXEL, BLAST2000
DOJO iMate X 20K Specifications | Design: 2FIRSTS

 

The main feature of DOJO PIXEL's products is that it is the "world's first e-cigarette equipped with a gravity sensor and dual pixel screens." Users can switch themes UI by shaking the device, and the device can display pixel-style UI animation designs when tilted or moved.

 

The recently launched product from the DOJO brand is the DOJO BLAST2000 GO, with its main product specifications listed in the table below:

 

New Releases from DOJO E-cigarette: iMate X 20K, PIXEL, BLAST2000
DOJO BLAST 2000 GO Parameters | Image source: 2FIRSTS

 

Unlike the iMate X 20K and PIXEL, the DOJO BLAST2000 GO is a product with a refillable design, equipped with a 2ml pre-filled pod and a 2ml refillable container, providing a total capacity of 4ml.

 

Currently, the iMate X 20K, PIXEL, and BLAST2000 GO are all available on the official website of the DOJO e-cigarette brand and are now online on some e-cigarette distributor websites.

 


2Firsts will continue to monitor the performance and market trends of e-cigarette products globally, providing the public with accurate and authoritative industry information.

 

2FIRSTS focuses on providing readers with the latest information on products in the tobacco industry. We welcome readers to submit articles to share the newest products in the e-cigarette field with us.

 

If you have any unique insights or information, feel free to contact us anytime via email at info@2firsts.com or reach out to 2Firsts CEO Alan Zhao on LinkedIn.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
AIR Invests $20 Million in Greentank, Deepening Capital Ties Across the Vape Supply Chain
AIR Invests $20 Million in Greentank, Deepening Capital Ties Across the Vape Supply Chain
Nasdaq-listed AIR Global has invested $20 million in preferred shares of Canadian vaporization technology company Greentank, deepening a partnership established in 2023. AIR gains a board nomination right, access to new technologies, enhanced commercial terms and long-term supply assurances, while retaining an option to increase its stake. Greentank’s Quantum Chip platform powers Crown Switch and forms part of AIR’s planned U.S. PMTA dossier, linking capital investment more closely with product technology, regulatory evidence and supply-chain control.
Special Report
Jul.29
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
A U.S. Customs and Border Protection proposal to collect foreign export declarations and other overseas customs documents could expose discrepancies in the value, classification and description of China-made vape shipments entering the United States. A veteran Chinese logistics professional told 2Firsts that the measure, if implemented, could undermine the all-inclusive shipping model used by some unauthorized vape exporters and push parts of the trade toward costlier underground channels. The risk extends beyond higher duties: accurately declared products may also be more readily identified as unauthorized e-cigarettes subject to FDA enforcement.
Special Report
Sep.07
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13